Annual report pursuant to Section 13 and 15(d)

Cover
- Cover
Financial Statements
Notes to Financial Statements
Accounting Policies
- SIGNIFICANT ACCOUNTING POLICIES (Policies)
Notes Tables
Notes Details

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.24.1

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)			1 Months Ended		12 Months Ended
	Nov. 09, 2023	Jan. 03, 2022	Mar. 29, 2023	Jul. 28, 2016	Dec. 31, 2023	Dec. 31, 2022
Related party payables					$ 1,683,453	$ 1,077,088
Per share value					$ 0.001	$ 0.001
Common Stock, Shares Issued					8,674,029	7,718,636
Ownership percentage					50.00%
BioCorRx Pharmaceuticals [Member]
Ownership percentage held by Company				75.80%
Lucido Subscription Agreement [Member]
Purchase price		$ 4.35	$ 1.75
Subscription aggregate amount receivable		$ 500,000	$ 300,000
Per share value		$ 0.001	$ 0.001
Common Stock, Shares Issued		114,943	171,296
2023 Q4 Lucido Subscription Agreement [Member]
Purchase price	$ 1.60
Subscription aggregate amount receivable	$ 7,500
Per share value	$ 0.001
Common Stock, Shares Issued	4,687
2023 Q4 Lucido Subscription Agreement [Member] \| Warrants [Member]
Purchase price	$ 2.00
Stock not issued					4,687
Subscription aggregate amount receivable	$ 7,500
Inducement shares issued	900
Common Stock, Shares Issued	7,500
Galligan Subscription Agreement [Member]
Purchase price	$ 1.60
Stock not issued					4,687
Subscription aggregate amount receivable	$ 7,500
Per share value	$ 0.001
Common Stock, Shares Issued	4,687
Galligan Subscription Agreement [Member] \| Warrants [Member]
Purchase price	$ 2.00
Stock not issued					4,687
Subscription aggregate amount receivable	$ 7,500
Inducement shares issued	900
Common Stock, Shares Issued	7,500
Minimum [Member] \| Joseph Galligan [Member]
Ownership percentage	15.00%		15.00%		15.00%
Maximum [Member] \| Joseph Galligan [Member]
Ownership percentage	20.00%		20.00%		20.00%

- References

No definition available.

+ Details

Name:	bicx_InducementSharesIssued
Namespace Prefix:	bicx_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- References

No definition available.

+ Details

Name:	bicx_NotesPayablesRelatedPartiesCurrentAndNoncurrent
Namespace Prefix:	bicx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- References

No definition available.

+ Details

Name:	bicx_OwnershipPercentageHeldByCompany
Namespace Prefix:	bicx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- References

No definition available.

+ Details

Name:	bicx_StockNotIssued
Namespace Prefix:	bicx_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 30
-Name Accounting Standards Codification
-Section 25
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481138/505-30-25-5

+ Details

Name:	us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Face amount or stated value per share of common stock.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of subscription receivable from investors who have been allocated common stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 310
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480833/946-310-45-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(5)(a)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

+ Details

Name:	us-gaap_CommonStockSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A

+ Details

Name:	us-gaap_VariableInterestEntityOwnershipPercentage
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_ConsolidatedEntitiesAxis=bicx_BioCorRxPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis=bicx_LucidoSubscriptionAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis=bicx_QFourLucidoSubscriptionAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=bicx_WarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis=bicx_GalliganSubscriptionAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=bicx_JosephGalliganMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: